Northwest Investment Counselors, LLC Crispr Therapeutics Ag Transaction History

Northwest Investment Counselors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$43.23 - $73.83 $3,804 - $6,497	-88 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$70.09 - $111.29 $6,167 - $9,793	88 New	88 $7,000
Q2 2021 Jul 22, 2021	SELL	$100.84 - $161.89 $8,873 - $14,246	-88 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$110.72 - $210.04 $9,743 - $18,483	88 New	88 $11,000
Q4 2020 Jan 26, 2021	SELL	$79.67 - $173.23 $7,010 - $15,244	-88 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$78.5 - $100.64 $6,908 - $8,856	88 New	88 $7,000

494

64.3M

1.68M

1.95M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.88B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

Stay updated on Northwest Investment Counselors, LLC with notifications on news.